Magnetic Seizure Therapy for Unipolar and Bipolar Depression: A Systematic Review

Abstract EN

Objective.

Magnetic seizure therapy (MST) is a novel, experimental therapeutic intervention, which combines therapeutic aspects of electroconvulsive therapy (ECT) and transcranial magnetic stimulation, in order to achieve the efficacy of the former with the safety of the latter.

MST might prove to be a valuable tool in the treatment of mood disorders, such as major depressive disorder (MDD) and bipolar disorder.

Our aim is to review current literature on MST.

Methods.

OVID and MEDLINE databases were used to systematically search for clinical studies on MST.

The terms “magnetic seizure therapy,” “depression,” and “bipolar” were employed.

Results.

Out of 74 studies, 8 met eligibility criteria.

There was considerable variability in the methods employed and samples sizes were small, limiting the generalization of the results.

All studies focused on depressive episodes, but few included patients with bipolar disorder.

The studies found reported significant antidepressant effects, with remission rates ranging from 30% to 40%.

No significant cognitive side effects related to MST were found, with a better cognitive profile when compared to ECT.

Conclusion.

MST was effective in reducing depressive symptoms in mood disorders, with generally less side effects than ECT.

No study focused on comparing MST to ECT on bipolar depression specifically.